These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30706777)

  • 1. Exosome-like Nanoparticles: A New Type of Nanocarrier.
    Fernandes M; Lopes I; Teixeira J; Botelho C; Gomes AC
    Curr Med Chem; 2020; 27(23):3888-3905. PubMed ID: 30706777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial exosomes for translational nanomedicine.
    Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
    J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Derived Nanovesicles as Exosome-Mimetics for Drug Delivery Purposes: Uses and Recommendations.
    Ou YH; Zou S; Goh WJ; Wang JW; Wacker M; Czarny B; Pastorin G
    Methods Mol Biol; 2021; 2211():147-170. PubMed ID: 33336276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
    Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
    Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celery (
    Lu X; Han Q; Chen J; Wu T; Cheng Y; Li F; Xia W
    J Agric Food Chem; 2023 Jun; 71(22):8413-8424. PubMed ID: 37222554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coincident Fluorescence-Burst Analysis of the Loading Yields of Exosome-Mimetic Nanovesicles with Fluorescently-Labeled Cargo Molecules.
    Sanaee M; Sandberg E; Ronquist KG; Morrell JM; Widengren J; Gallo K
    Small; 2022 Mar; 18(12):e2106241. PubMed ID: 35084110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic and Post-Translational Modification Profiling of Exosome-Mimetic Nanovesicles Compared to Exosomes.
    Nasiri Kenari A; Kastaniegaard K; Greening DW; Shambrook M; Stensballe A; Cheng L; Hill AF
    Proteomics; 2019 Apr; 19(8):e1800161. PubMed ID: 30790448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research status and challenges of plant-derived exosome-like nanoparticles.
    Bai C; Liu J; Zhang X; Li Y; Qin Q; Song H; Yuan C; Huang Z
    Biomed Pharmacother; 2024 May; 174():116543. PubMed ID: 38608523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
    Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
    J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
    Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
    J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.
    Li DF; Yang MF; Xu J; Xu HM; Zhu MZ; Liang YJ; Zhang Y; Tian CM; Nie YQ; Shi RY; Wang LS; Yao J
    Int J Nanomedicine; 2022; 17():3893-3911. PubMed ID: 36092245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the development and establishment of exosome-based drug delivery systems.
    Wang J; Chen D; Ho EA
    J Control Release; 2021 Jan; 329():894-906. PubMed ID: 33058934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.